(2,6-DIAMINO-9H-PURIN-9-YL)-5-(HYDROXYMETHYL)-1,2-CYCLOPENTANEDIOL, REL-(1R,2R,3S,5S)-3-
UNII NZ3L573MR2
Substance Identification & Data
This profile provides standardized clinical and technical data for (2,6-diamino-9h-purin-9-yl)-5-(hydroxymethyl)-1,2-cyclopentanediol, Rel-(1r,2r,3s,5s)-3-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) NZ3L573MR2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 108742-10-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C11H16N6O3 ZLJQBJBJBIATTP-KYNKHSRBSA-N;ZLJQBJBJBIATTP-DGCAKLBHSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (2,6-diamino-9h-purin-9-yl)-5-(hydroxymethyl)-1,2-cyclopentanediol, Rel-(1r,2r,3s,5s)-3-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.